Diagnosis of Structural Heart Disease Using MCG

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2914 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-18

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this prospective cohort study is to determine the parameters of cardiac magnetic imaging to identify structural heart disease using use transthoracic echocardiography or cardiac magnetic resonance as reference standard.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

NCT06197724

Non ST Segment Elevation Acute Coronary Syndrome

RECRUITING

MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease

NCT06123728

Stable Coronary Artery Disease

RECRUITING

Magnetocardiography in the Accurate Identification of Myocardial Infarction

NCT05896826

Chest Pain Acute Coronary Syndrome Myocardial Infarction

RECRUITING

Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard

NCT06255769

Chest Pain Stenosis Myocardial Ischemia

RECRUITING

Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis

NCT05392712

Chest Pain, Acute Coronary Syndrome, Myocardial Infarction

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Structural Heart Abnormality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Training and testing cohort

Magnetocardiography

Intervention Type DEVICE

Magnetocardiography

External validation cohort

Magnetocardiography

Intervention Type DEVICE

Magnetocardiography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetocardiography

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those with suspected structural heart disease who are scheduled to undergo echocardiography or cardiac magnetic resonance. Structural heart disease includes cardiomyopathy (hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, etc.), congenital heart disease (including ventricular septal defect, atrial septal defect, patent ductus arteriosus, Tetralogy of Fallot) syndrome, tricuspid valve malformation, etc.), valvular heart disease (aortic valve stenosis, mitral valve stenosis, etc.), ventricular remodeling caused by myocardial ischemia or cardiac structural changes.
* Signed the consent form.

Exclusion Criteria

* Those with atrial fibrillation, supraventricular tachycardia, atrioventricular block and other arrhythmias that have not returned to normal;
* Those who are thought to be incapable of completing the relevant examinations by an attending physicians (or physicians with higher qualifications) due to unstable clinical conditions, metal implants, etc., or those who are unable to perform the examinations;
* Those with obvious abnormal thyroid function, severe anemia or other blood diseases and other diseases that obviously affect the circulating blood supply;
* Those with malignant tumors;
* Pregnant or lactating women.

Eligible Sex

ALL

Accepts Healthy Volunteers

No